Equities

Medadvisor Ltd

Medadvisor Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.535
  • Today's Change-0.005 / -0.93%
  • Shares traded220.17k
  • 1 Year change+137.78%
  • Beta0.5204
Data delayed at least 20 minutes, as of Jul 26 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MedAdvisor Limited is an Australia-based company that is engaged in digital medication adherence solutions. The Company's segments include Australia, the United States, the United Kingdom and Asia Operations. The Company's products suite includes Medication Management Application, PlusOne Pharmacy Software and Pharma Patient Experience Platform. The Medication Management Application connects to the pharmacy from the mobile phone. The Company's subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam UK Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.

  • Revenue in AUD (TTM)109.43m
  • Net income in AUD-9.03m
  • Incorporated2010
  • Employees100.00
  • Location
    Medadvisor LtdL 2 971 Burke Road, CamberwellMELBOURNE 3124AustraliaAUS
  • Phone+61 39095-3036
  • Fax+61 39882-3317
  • Websitehttps://www.medadvisor.com.au
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Genetic Signatures Ltd16.49m-18.04m169.93m----3.45--10.30-0.1245-0.12450.11360.21720.33661.065.25---36.81-7.14-40.19-7.8240.6657.68-109.38-13.745.95-18,040.000.0003---38.1133.44-558.77--73.20--
EMvision Medical Devices Ltd8.86m-3.22m170.00m----27.17--19.19-0.0449-0.04490.11860.07330.7954-------28.95-67.20-45.25-79.38-----36.40-175.99---35.200.3424--62.0870.4736.64------
Cyclopharm Limited32.21m-4.70m177.82m87.00--4.67--5.52-0.0508-0.05080.34760.34280.67481.114.13370,173.10-9.85-12.60-11.92-14.9468.1570.20-14.60-25.472.32-18.400.1159--11.2215.5028.90---7.83-12.94
Optiscan Imaging Ltd1.68m-5.44m179.60m8.00--10.96--106.90-0.0074-0.00740.00230.01960.1344-0.52531.48---43.54-47.55-50.01-57.08148.555.08-323.87-254.449.43--0.0269--65.86-5.23-2.80---15.27--
4DMedical Ltd1.03m-30.83m211.42m----2.21--206.22-0.0882-0.08820.00290.23320.00980.0920.1585---29.47-43.96-39.07-57.5895.0032.30-3,007.64-2,704.361.79--0.0476---31.84-1.86-27.92--2.46--
Aroa Biosurgery Ltd62.18m-9.57m216.85m261.00--2.54--3.49-0.0278-0.02780.18080.24830.6071.562.82---9.34-10.37-10.11-12.5285.3980.63-15.39-20.316.40--0.0726--9.0124.26-2,583.84--33.65--
Medadvisor Ltd109.43m-9.03m294.54m100.00--5.25--2.69-0.0166-0.01660.20060.1020.9056--4.68---7.47-24.51-13.47-36.7658.8959.77-8.25-26.98---3.040.1847--44.6067.6634.83---15.12--
Anteris Technologies Ltd7.03m-67.33m300.83m1.00--9.75--42.81-4.30-4.300.45031.610.20322.726.69---199.17-120.86-288.53-189.2777.3266.40-980.31-316.852.55-52.000.0804--4.48-22.85-51.86--42.27--
EBR Systems Inc0.00-53.59m332.76m----6.98-----0.185-0.1850.000.15470.00-------46.54---50.70-------------28.660.5609-------5.89------
Data as of Jul 26 2024. Currency figures normalised to Medadvisor Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

14.96%Per cent of shares held by top holders
HolderShares% Held
Perennial Value Management Ltd.as of 16 Apr 202465.71m11.94%
Norges Bank Investment Managementas of 31 Dec 202316.41m2.98%
DFA Australia Ltd.as of 30 Jun 2024246.85k0.05%
Data from 31 Jul 2021 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.